Navigation Links
OriGene Releases Bioactive Full-length Human MTOR Protein
Date:2/1/2011

ROCKVILLE, Md., Feb. 1, 2011 /PRNewswire/ -- OriGene Technologies, Inc., a gene-centric life sciences company, releases the first commercially available full length human MTOR protein with superior biological activity.

MTOR is a serine/threonine protein kinase which regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. Purified, functional MTOR is highly desirable in high throughput functional screening assays and drug target discovery.

Produced in mammalian cells, OriGene MTOR protein maintains the most authentic protein structure compared to truncated forms of the protein produced in bacterial or insect cells. When tested in a homogeneous time-resolved fluorescent (HTRF®) assay, OriGene full-length MTOR demonstrated a high level of serine/threonine kinase activity.   To learn more about OriGene MTOR protein and related products, visit www.origene.com/protein/TP320457/MTOR.aspx.

To date, OriGene has released 5,000 recombinant human proteins made in HEK293 cells. This is the largest collection of full-length human proteins made in human cells. These full length human proteins are widely used in protein function studies, assay development, and high throughput screening, both in academia and industry. For many important drug targets, OriGene offers complete services from clone construction, protein expression, to monoclonal antibody and assay development.   To learn more about OriGene full length human protein offering, visit www.origene.com/protein.

About OriGene Technologies

OriGene Technologies, Inc. is a gene-centric life sciences company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene's gene based toolbox allows life science researchers to study all genes and gene functions. OriGene's mission is to be "Your Gene Company," and we are dedicated to developing the most comprehensive technology and tools for everything a researcher would need for gene based research.

For more information, visit www.origene.com.  


'/>"/>
SOURCE OriGene Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector
2. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China
3. OriGene Launches 5,000 Purified Human Proteins from HEK293 Cells
4. OriGene Technologies Acquires Marligen Biosciences
5. OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
6. OriGene Technologies, Inc. to Build the Worlds Largest TrueMAB(TM) Monoclonal Antibody Facility in Wuxi, China
7. OriGene Technologies Launches Over 5,000 Heavy Isotope Labeled Full-Length Human Proteins as Quantitative Internal Standards for SRM/MRM Mass Spectrometry
8. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
9. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
10. Aureus Pharma Releases New Unified Knowledge Database
11. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 ... genomic services and solutions with cutting edge next-generation sequencing ... completed a USD $75 Million [515 Million RMB] B ... International Capital Management ( Shenzhen ) Co., ... ("SDIC Innovation") and Shanghai Sigma Square Investment Center LP ...
(Date:11/30/2016)... -- Part of 5m$ Investment in Integrated Drug ... , ... today announced that it had successfully completed the expansion of ... increased the Screening Collection to over 400,000. The new compounds ... the company. This expansion, complemented by new robotics and compound ...
(Date:11/30/2016)... ... November 30, 2016 , ... SSCI, the established leader in small-molecule cocrystal ... the latest FDA guidance on pharmaceutical cocrystals as drug substance . The ... , The event follows the successful November 15th event that took place in ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... of a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s ...
Breaking Biology Technology:
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... On Monday, the Department of Homeland Security ... solutions for the Biometric Exit Program. The Request for ... (CBP), explains that CBP intends to add biometrics to ... United States , in order to deter visa ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... control systems is proud to announce the introduction of fingerprint attendance control software, allowing ... are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
Breaking Biology News(10 mins):